Section 59
Chapter 58,645

Prophylactic exercises among head and neck cancer patients during and after swallowing sparing intensity modulated radiation: adherence and exercise performance levels of a 12-week guided home-based program

Cnossen, I.C.; van Uden-Kraan, C.F.; Witte, B.I.; Aalders, Y.J.; de Goede, C.J.T.; de Bree, R.; Doornaert, P.; Rietveld, D.H.F.; Buter, J.; Langendijk, J.A.; Leemans, C.René.; Verdonck-de Leeuw, I.M.

European Archives of Oto-Rhino-Laryngology Official Journal of the European Federation of Oto-Rhino-Laryngological Societies Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 274(2): 1129-1138


ISSN/ISBN: 0937-4477
PMID: 27812787
DOI: 10.1007/s00405-016-4367-9
Accession: 058644085

Download citation:  

The background and purpose of this paper is to investigate adherence, exercise performance levels and associated factors in head and neck cancer (HNC) patients participating in a guided home-based prophylactic exercise program during and after treatment [swallowing sparing intensity modulated radiation therapy (SW-IMRT)]. Fifty patients were included in the study. Adherence was defined as the percentage of patients who kept up exercising; exercise performance level was categorized as low: ≤1, moderate: 1-2, and high: ≥2 time(s) per day, on average. Associations between 6- and 12-week exercise performance levels and age, gender, tumour site and stage, treatment, intervention format (online or booklet), number of coaching sessions, and baseline HNC symptoms (EORTC-QLQ-H&N35) were investigated. Adherence rate at 6 weeks was 70% and decreased to 38% at 12 weeks. In addition, exercise performance levels decreased over time (during 6 weeks: 34% moderate and 26% high; during 12 weeks: 28% moderate and 18% high). The addition of chemotherapy to SW-IMRT [(C)SW-IMRT] significantly deteriorated exercise performance level. Adherence to a guided home-based prophylactic exercise program was high during (C)SW-IMRT, but dropped afterwards. Exercise performance level was negatively affected by chemotherapy in combination with SW-IMRT.

PDF emailed within 0-6 h: $19.90